See Recent Shionogi-Sponsored Congress Presentations

Congresses

As part of our commitment to addressing unmet medical needs, Shionogi continues to investigate approved products and pipeline compounds. Shionogi presents its research at major congress events globally.

The content contained herein is for your information only. No reproduction, alteration, or distribution of this information is permitted. Information about investigational compounds or investigational uses of products does not imply FDA approval of these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the investigational compounds or investigational uses will receive FDA approval. Shionogi does not recommend or suggest use of its products in a manner inconsistent with FDA-approved labeling.

Select a congress event or filter to view available congress presentations.

  • All
  • APCCMI
  • ASCP
  • ASM Microbe
  • AVG and IMRP
  • CROI
  • ESCMID
  • GSA
  • IAS
  • IDWeek
  • NACFC
  • SCCM
  • All
  • 2025
  • 2024
  • All
  • Gram-negative infection
  • COVID-19
  • All
  • Cefiderocol
  • Ensitrelvir
  • Xeruborbactam
  • S-892216
  • All
  • Oral presentation
  • Poster presentation

You Are Viewing Presentations

IDWeek 2025
Cefiderocol

Outcomes of patients treated with cefiderocol for infections caused by β-lactam–β-lactamase inhibitor non-susceptible bacteria: subgroup analysis of the PROVE study

View/Download Presentation
IDWeek 2025
Xeruborbactam

Pharmacodynamic assessment of combination of cefiderocol with xeruborbactam in murine thigh infection model

View/Download Presentation
ESCMID 2024
Ensitrelvir

Pharmacokinetics, safety, and tolerability of ensitrelvir, a novel oral inhibitor of 3C-like protease of SARS-CoV-2, in participants with hepatic impairment

View/Download Presentation
ESCMID 2025
Ensitrelvir

Phenotyping and genotyping analysis using baseline swab samples in ensitrelvir clinical studies

View/Download Presentation
IDWeek 2025
Cefiderocol

Population pharmacokinetic/pharmacodynamic analysis of cefiderocol in Chinese patients with complicated urinary tract infections

View/Download Presentation
IDWeek 2024
Ensitrelvir

Pre-exposure prophylactic treatment with ensitrelvir inhibited SARS-CoV-2 infection in hamster aerosol transmission model

View/Download Presentation

You Are Viewing Congress Locations